Non-interventional Study on the Safety and Efficacy for Prevention and Treatment of Fungal Infections in Paediatric Patients in Asia/Oceania - ERADICATE Study
Phase of Trial: Phase IV
Latest Information Update: 05 Oct 2017
At a glance
- Drugs Micafungin (Primary)
- Indications Mycoses
- Focus Adverse reactions
- Acronyms ERADICATE
- Sponsors Astellas Pharma
- 20 Jul 2017 Planned End Date changed from 31 Jan 2020 to 1 Nov 2019.
- 20 Jul 2017 Planned primary completion date changed from 31 Dec 2019 to 1 Nov 2019.
- 20 Jul 2017 Status changed from not yet recruiting to recruiting.